| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 45 |
| 1 | ASPIRIN | 25 |
| 2 | ASPIRIN 325 MG | 25 |
| 3 | ASPIRIN 81 MG | 25 |
| 4 | CLOPIDOGREL | 14 |
| 5 | CLOPIDOGREL BISULFATE | 14 |
| 6 | FULVESTRANT | 14 |
| 7 | RIBOCICLIB | 14 |
| 8 | AMANTADINE | 13 |
| 9 | L DOPA | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L DOPA | 12 | 0.0448 |
| 1 | NADOFARAGENE FIRADENOVEC-VNCG | 1 | 0.0019 |
| 2 | DESFLURANE | 2 | 0.0012 |
| 3 | AMANTADINE | 13 | 0.0010 |
| 4 | ANTI-INHIBITOR COAGULANT COMPLEX | 1 | 0.0009 |
| 5 | ROPIVACAINE HYDROCHLORIDE | 2 | 0.0008 |
| 6 | TOLNAFTATE | 1 | 0.0008 |
| 7 | MIFEPRISTONE | 3 | 0.0006 |
| 8 | DROPERIDOL | 1 | 0.0006 |
| 9 | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE CAPSULES | 1 | 0.0006 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Influenza A M2 Protein Inhibitor [EPC] | 13 | 0.0008 |
| 2 | Progestin Antagonist [EPC] | 3 | 0.0006 |
| 3 | Estrogen Receptor Antagonist [EPC] | 14 | 0.0003 |
| 4 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 5 | Factor Xa Inhibitor [EPC] | 73 | 0.0003 |
| 6 | Aromatic Amino Acid [EPC] | 13 | 0.0002 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 1 | 0.0002 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 1 | 0.0002 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 18 | 0.0002 |